Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies
about
The Dark Side of the Moon - the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management.Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers.Phase 0 clinical trials in oncology new drug development.Mathematical framework for activity-based cancer biomarkers.Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathwayMolecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.Guiding the optimal translation of new cancer treatments from canine to human cancer patients.Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents.Phase zero trials: a novel approach in drug development process.Brain Tumor Clinical Trials: Perspective 2014.Targeting angiogenesis in melanoma
P2860
Q34095802-F1CCC566-ABD4-4465-8EAA-16A9902D9F12Q34282732-8F0669CF-BC90-4EA9-B946-6CA41BB5CB8AQ34941964-250DFC31-2B53-4974-9DCD-66A79866DB66Q36179245-E5A1FCA8-0900-429E-9AE2-D9CA92315698Q37027010-4A04E843-5809-4606-A03A-91F66C9A022CQ37092020-63F0494A-F86B-492C-8900-3F5B89B4DD7FQ37357412-B543EC6D-C05D-4EC0-AE4E-EE5771717D6BQ37403232-7D8FE828-269D-4EA7-AA90-84D0A79615F2Q38119561-19343AF5-FC63-4709-8007-B19A9F78AA72Q52151988-D9167B0A-ACC2-4506-BF4F-D92DBE169BC4Q57569703-47303199-9035-43D1-BFA2-FAC2F2C929F3
P2860
Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@ast
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@en
type
label
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@ast
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@en
prefLabel
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@ast
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@en
P2093
P2860
P1476
Phase 0 clinical trials: recom ...... of Innovative Cancer Therapies
@en
P2093
A Hilary Calvert
Giuseppe Giaccone
James H Doroshow
Joseph E Tomaszewski
Marinus Lobbezoo
Shivaani Kummar
Task Force on Methodology for the Development of Innovative Cancer Therapies (MDICT)
P2860
P304
P356
10.1016/J.EJCA.2008.10.024
P577
2008-12-16T00:00:00Z